Line 275: | Line 275: | ||
<br> | <br> | ||
<div id="content2"> | <div id="content2"> | ||
− | <div style="font-size:12px"><i> | + | <div style="font-size:12px"><i><b>Figure 7:</b> <b>a</b> We worked with TAS_Taipei to validate the ElectroPen’s efficacy, and through two trials conducted, they successfully demonstrated that electroporation using the device was successful. <b>b</b> Collaboration with the University of Georgia team on 3 different trials also indicated the same results, validating the performance of the ElectroPen. |
+ | </i></div> | ||
<br><br> | <br><br> | ||
</div> | </div> |
Revision as of 18:37, 17 October 2018
E N T R E P R E N E U R S H I P
ENTREPRENEURSHIP
A key component of demonstrating the accuracy and precision of scientific data is through reproducibility and external validation. We believe that collaboration with other iGEM teams is a powerful method to disseminate information, and in this spirit, we have worked with the University of Georgia iGEM Team and Taipei American School iGEM Team (TAS_Taipei) to verify the functionality and practicality of our device. Throughout multiple trials conducted by both teams, the ElectroPen was demonstrated to successfully electroporate GFP into E. coli, as seen with the trials conducted by Lambert iGEM. The transformation efficiency obtained from these tests is also on par with those from commercial electroporators, thereby confirming the data obtained across all trials conducted. Through this, we demonstrate that the ElectroPen (patent pending) is a powerful ultralow-cost device that can be applied in various settings from low-resource high school groups to equipped university laboratories, and we envision the application of this device in these settings across the world.
In order to ensure effective implementation of this device across the world, we have received feedback and design inputs for improvements and suggestions for the ElectroPen.
In order to ensure effective implementation of this device across the world, we have received feedback and design inputs for improvements and suggestions for the ElectroPen.
Figure 7: a We worked with TAS_Taipei to validate the ElectroPen’s efficacy, and through two trials conducted, they successfully demonstrated that electroporation using the device was successful. b Collaboration with the University of Georgia team on 3 different trials also indicated the same results, validating the performance of the ElectroPen.